Phase I trial assesses safety and tolerability of KW-2450 in pretreated advanced solid tumors June 10, 2011
OSI claims new inhibitors of insulin-like growth factor 1 receptor and/or insulin receptor June 10, 2011
Interim data from first-in-human trial of Pfizer's CVX-241 support safety in advanced solid tumors June 9, 2011
RSS